Statin Withdrawal and Treating COVID-19 Patients

preprint OA: gold publisher-OA-unknown
📄 Open PDF View at publisher

Abstract

Most but not all observational studies of statin treatment of COVID-19 patients suggest that treatment improves outcomes. However, almost all observational studies fail to consider what cardiovascular investigators have known for 15-20 years: withdrawing statins after hospital admission has detrimental effects on patient outcomes. Continuing (or starting) statin treatment after hospital admission consistently improves COVID-19 patient outcomes, whereas discontinuing treatment does not. Thus, observational studies of the effectiveness of statin treatment of COVID-19 patients must consider the consequences of statin withdrawal.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: publisher-OA-unknown · commercial use NOT OK · attribution required